Uncertainty in the Development and Launch of New Pesticides
First written in FY2016. 1 of 3 entries say "Worsened", first in FY2017. Latest entry: FY2020.
The whole theme swung hardest in 2022: 20 of 40 companies on the "Worse" side.
28 other companies' latest entry also says "Restated".
- FY2020RestatedAnnual report
「登録の取得には、厳格な手続きと多様な試験が要求され、およそ十年の歳月と数十億円に及ぶ経費を要すると想定されます。」
新規農薬の開発・登録にはおよそ10年と数十億円の経費を要するとの不確実性が、研究開発体制の説明でも示された。 - FY2017WorsenedAnnual report
「さらに、法規制の改正や消費者の関心の変化により安全性評価や環境影響評価等の要求が増大した場合には新規薬剤の開発コストが上昇する可能性があります。」
従来の開発遅延・中止、承認取得による上市延期・断念のリスクに加え、安全性・環境影響評価の要求増大による開発コスト上昇が明示された。 - FY2016First statedAnnual report
「Developing new crop protection products requires substantial research and development investment and a long period of time. If useful effects are not discovered in efficacy or crop-safety testing, development may not proceed as planned and may be extended or discontinued. In Japan and overseas markets, legal regulations including crop protection laws apply, and manufacturing and launching new products requires approval based on rigorous country-specific reviews. As a result, launches may be delayed or abandoned.」
The disclosure identifies risks of extended or discontinued development, delayed or abandoned launches due to regulatory approvals, and higher development costs.